
Jason A. Deck
Examiner (ID: 15662, Phone: (571)270-5753 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627 |
| Total Applications | 619 |
| Issued Applications | 298 |
| Pending Applications | 2 |
| Abandoned Applications | 319 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9397050
[patent_doc_number] => 20140094456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'ANTI-FIBROTIC PYRIDINONES'
[patent_app_type] => utility
[patent_app_number] => 13/799727
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 97666
[patent_no_of_claims] => 165
[patent_no_of_ind_claims] => 95
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13799727
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/799727 | ANTI-FIBROTIC PYRIDINONES | Mar 12, 2013 | |
Array
(
[id] => 10514457
[patent_doc_number] => 09241486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-26
[patent_title] => 'Combination and methods for controlling turfgrass pests'
[patent_app_type] => utility
[patent_app_number] => 13/790375
[patent_app_country] => US
[patent_app_date] => 2013-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4468
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13790375
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/790375 | Combination and methods for controlling turfgrass pests | Mar 7, 2013 | Issued |
Array
(
[id] => 8866681
[patent_doc_number] => 20130150384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'METHOD FOR TREATMENT OF BRAIN CANCERS'
[patent_app_type] => utility
[patent_app_number] => 13/768022
[patent_app_country] => US
[patent_app_date] => 2013-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 8673
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13768022
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/768022 | METHOD FOR TREATMENT OF BRAIN CANCERS | Feb 14, 2013 | Abandoned |
Array
(
[id] => 10202709
[patent_doc_number] => 20150087697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCLE PAIN'
[patent_app_type] => utility
[patent_app_number] => 14/399522
[patent_app_country] => US
[patent_app_date] => 2013-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9969
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399522
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399522 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCLE PAIN | Jan 24, 2013 | Abandoned |
Array
(
[id] => 8822319
[patent_doc_number] => 20130123364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'N6-(1-IMINOETHYL)-L-LYSINE FOR REGENERATION OF ALVEOLI IN LUNGS'
[patent_app_type] => utility
[patent_app_number] => 13/737774
[patent_app_country] => US
[patent_app_date] => 2013-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 1500
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13737774
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/737774 | N6-(1-IMINOETHYL)-L-LYSINE FOR REGENERATION OF ALVEOLI IN LUNGS | Jan 8, 2013 | Abandoned |
Array
(
[id] => 9042472
[patent_doc_number] => 20130245110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'USE FOR CANNABINOIDS'
[patent_app_type] => utility
[patent_app_number] => 13/735108
[patent_app_country] => US
[patent_app_date] => 2013-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13415
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13735108
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/735108 | USE FOR CANNABINOIDS | Jan 6, 2013 | Abandoned |
Array
(
[id] => 9562070
[patent_doc_number] => 20140179784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'LEVOTHYROXINE FORMULATION WITH CARRAGEENAN'
[patent_app_type] => utility
[patent_app_number] => 13/723500
[patent_app_country] => US
[patent_app_date] => 2012-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3389
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13723500
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/723500 | LEVOTHYROXINE FORMULATION WITH CARRAGEENAN | Dec 20, 2012 | Abandoned |
Array
(
[id] => 9175042
[patent_doc_number] => 20130317027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'COMPOUNDS AND THERAPEUTIC USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/708235
[patent_app_country] => US
[patent_app_date] => 2012-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 102058
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13708235
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/708235 | COMPOUNDS AND THERAPEUTIC USES THEREOF | Dec 6, 2012 | Abandoned |
Array
(
[id] => 8721283
[patent_doc_number] => 20130072500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/676963
[patent_app_country] => US
[patent_app_date] => 2012-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56003
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13676963
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/676963 | Pyrimidyl cyclopentanes as Akt protein kinase inhibitors | Nov 13, 2012 | Issued |
Array
(
[id] => 8866692
[patent_doc_number] => 20130150395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/660112
[patent_app_country] => US
[patent_app_date] => 2012-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 15569
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13660112
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/660112 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof | Oct 24, 2012 | Issued |
Array
(
[id] => 8780705
[patent_doc_number] => 20130102680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'METHODS FOR SELECTIVE SILENCING OF SENSORY NEURONS'
[patent_app_type] => utility
[patent_app_number] => 13/647678
[patent_app_country] => US
[patent_app_date] => 2012-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 14425
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13647678
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/647678 | METHODS FOR SELECTIVE SILENCING OF SENSORY NEURONS | Oct 8, 2012 | Abandoned |
Array
(
[id] => 8567296
[patent_doc_number] => 20120329867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR THE PREPARATION OF A MEDICAMENT FOR ADMINISTRATION SHORTLY AFTER AMIODARONE DISCONTINUATION'
[patent_app_type] => utility
[patent_app_number] => 13/605343
[patent_app_country] => US
[patent_app_date] => 2012-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4531
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13605343
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/605343 | USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR THE PREPARATION OF A MEDICAMENT FOR ADMINISTRATION SHORTLY AFTER AMIODARONE DISCONTINUATION | Sep 5, 2012 | Abandoned |
Array
(
[id] => 8733776
[patent_doc_number] => 20130079346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => 'BENZOIC ACID DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/603602
[patent_app_country] => US
[patent_app_date] => 2012-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50940
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13603602
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/603602 | Benzoic acid derivatives | Sep 4, 2012 | Issued |
Array
(
[id] => 8567215
[patent_doc_number] => 20120329786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'COMPOUNDS AND THERAPEUTIC USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/601879
[patent_app_country] => US
[patent_app_date] => 2012-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 91400
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13601879
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/601879 | COMPOUNDS AND THERAPEUTIC USES THEREOF | Aug 30, 2012 | Abandoned |
Array
(
[id] => 9823736
[patent_doc_number] => 08933221
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-13
[patent_title] => 'Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds'
[patent_app_type] => utility
[patent_app_number] => 13/596208
[patent_app_country] => US
[patent_app_date] => 2012-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32708
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13596208
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/596208 | Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds | Aug 27, 2012 | Issued |
Array
(
[id] => 8586962
[patent_doc_number] => 20130005783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'Prevention And Treatment Of Diseases Caused By Elevated Levels Of Deoxy-Sphingolipids'
[patent_app_type] => utility
[patent_app_number] => 13/594153
[patent_app_country] => US
[patent_app_date] => 2012-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4608
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13594153
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/594153 | Prevention And Treatment Of Diseases Caused By Elevated Levels Of Deoxy-Sphingolipids | Aug 23, 2012 | Abandoned |
Array
(
[id] => 9597727
[patent_doc_number] => 20140194409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'Method of administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia'
[patent_app_type] => utility
[patent_app_number] => 14/126499
[patent_app_country] => US
[patent_app_date] => 2012-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4062
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14126499
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/126499 | Method of administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia | Jun 19, 2012 | Issued |
Array
(
[id] => 9538453
[patent_doc_number] => 20140163100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'Methods of Treating Multiple Sclerosis and Preserving and/or Increasing Myelin Content'
[patent_app_type] => utility
[patent_app_number] => 14/119373
[patent_app_country] => US
[patent_app_date] => 2012-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12132
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14119373
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/119373 | Methods of Treating Multiple Sclerosis and Preserving and/or Increasing Myelin Content | May 24, 2012 | Abandoned |
Array
(
[id] => 9319388
[patent_doc_number] => 20140051726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => '5-HT4 Receptor Agonist as a Prokinetic Agent'
[patent_app_type] => utility
[patent_app_number] => 14/006550
[patent_app_country] => US
[patent_app_date] => 2012-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4456
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14006550
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/006550 | 5-HT4 receptor agonist as a prokinetic agent | Mar 22, 2012 | Issued |
Array
(
[id] => 9223583
[patent_doc_number] => 20140018358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'BENZO [B] [1,4] OXAZIN DERIVATIVES AS CALCIUM SENSING RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/005944
[patent_app_country] => US
[patent_app_date] => 2012-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45256
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14005944
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/005944 | Benzo [B] [1,4] oxazin derivatives as calcium sensing receptor modulators | Mar 15, 2012 | Issued |